<DOC>
	<DOCNO>NCT02665299</DOCNO>
	<brief_summary>When DNA inside human cell undergoes certain alteration ( mutation ) , cell may develop cancer . The cancer cell may shed DNA blood stream . This circulate tumor DNA ( ctDNA ) detect sensitive , specialized laboratory test . Measurement ctDNA show useful following patient know cancer . It also find circulation patient early stage cancer . The purpose study examine blood specimen presence ctDNA individual without know cancer schedule undergo screen diagnostic colonoscopy order see ctDNA test detect cancer precancerous condition early stage patient become symptomatic . The result study help define role ctDNA detection early stage colon cancer define sensitive ( i.e . well pick cancer present ) specific ( i.e . often ctDNA find patient benign disease abnormality ) .</brief_summary>
	<brief_title>Plasma ctDNA Patients Undergoing Diagnostic Colonoscopy</brief_title>
	<detailed_description>After participant undergone inform consent process , 30 milliliter ( approximately two tablespoon ) blood drawn . This do prior schedule screen diagnostic colonoscopy . If patient indicate desire receive result test , receive write description , primary care physician . The patient contact yearly 5 year study staff learn whether find diagnosis colon cancer .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Colonic Polyps</mesh_term>
	<criteria>. 18 year age old schedule undergo screen diagnostic colonoscopy Dr. Phillip Fleshner Prior history cancer exclude basal cell carcinoma skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>colon polyp</keyword>
	<keyword>colon adenoma</keyword>
	<keyword>colonoscopy</keyword>
	<keyword>circulate tumor DNA</keyword>
</DOC>